MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2019 International Congress

    Social work support is associated with better health-related quality of life in late stage Parkinson’s disease

    P. Gonzalez-Latapi, M. Rafferty, S. Wu, H. Chen, T. Simuni (Chicago, IL, USA)

    Objective: Compare clinical and demographic characteristics of people with Parkinson’s disease (PD) who use social work/counseling services (SW-U) with non-users. Describe if PD Centers of…
  • 2019 International Congress

    Non-motor symptoms in Myoclonus-Dystonia: a comparison to other dystonia subtypes

    E. Timmers, M. Smit, A. Kuiper, A. Bartels, S. Vander Veen, A. Vander Stouwe, P. Santens, B. Bergmans, M. Tijssen (Groningen, Netherlands)

    Objective: Systematically study NMS in M-D in direct comparison to other types of dystonia and healthy controls. Background: Myoclonus-dystonia (M-D) due to a SGCE mutation…
  • 2019 International Congress

    Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.

    I. Aracil-Bolaños, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, S. Martínez-Horta, JM. González-de-Echávarri, J. Pérez-Pérez, H. Bejr-Kasem, B. Pascual-Sedano, MA. Boti, A. Campolongo, C. Izquierdo, A. Gironell, B. Gómez-Ansón, J. Pagonabarraga, J. Kulisevksy (Barcelona, Spain)

    Objective: To profile the neural correlates of neuropsychological assessment according to the Movement Disorders Society Task Force Criteria in its Level-1 and Level-2 recommendations Background:…
  • 2019 International Congress

    Measurement properties of the MDS-NMS Non-motor Fluctuations Subscale

    MJ. Forjaz, A. Ayala, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Philadelphia, PA, USA)

    Objective: This study aims at describing the measurement properties of the Non-motor Fluctuations (NMFs) subscale of the Movement Disorders Society Non-Motor Rating Scale (MDS-NMS) according…
  • 2019 International Congress

    Motor and non-motor symptoms burden, autonomy, quality of life and principal caregiver status is worse in patients with 5-2-1 positive criteria: a simple screening tool for identifying PD patients who need an optimization of Parkinson´s treatment.

    D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros (A Coruña, Spain)

    Objective: To compare quality of life (QoL), non-motor symptoms (NMS) burden, autonomy for activities of daily living (ADL) and patient´s principal caregiver status in PD…
  • 2019 International Congress

    Fatigue in Parkinson’s disease and its relation with disease duration and treatment

    D. Nassif, J. Pereira (Rio de Janeiro, Brazil)

    Objective: Identify the presence of fatigue in a population of PD patients, establishing its association with disease duration and treatment. Background: Fatigue is one of…
  • 2019 International Congress

    Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese

    M. Olchik, C. Rieder, L. Scudeiro, R. Millette, R. Rech, A. Ayres (Porto Alegre, Brazil)

    Objective: The aim of this study was to compare the efficiency  of the short form of Montreal Cognitive Assessment (s-MoCa) which has been validated in…
  • 2019 International Congress

    Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert

    MY. Gang, T. Baba, Y. Hosokai, Y. Nishio, A. Kikuchi, K. Hirayama, T. Hasegawa, M. Aoki, A. Takeda, E. Mori, K. Suzuki (Sendai, Japan)

    Objective: We investigated characteristics of clinical and cerebral glucose metabolic abnormalities in Parkinson’s disease (PD) with atrophy in the nucleus basalis of Meynert (NBM). Background:…
  • 2019 International Congress

    Pulmonary function in patients with Parkinson’s disease

    V. Israel, B. Yamaguchi, M. Ferreira, S. Valderramas (Curitiba, Brazil)

    Objective: Analyse the pulmonary function in patients with PD. Background: Respiratory disorders are the most common causes of death in people with Parkinson's disease (PD)(1,2).…
  • 2019 International Congress

    Higher levels of physical activity is associated with fewer non-motor symptoms in early Parkinson’s disease: a 1-year follow-up study

    S. Ng, N. Chia, M. Abbas, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: To examine the physical activity (PA) level in early Parkinson’s disease (PD) patients and its association with non-motor symptoms (NMS). Background: Lower PA is…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley